UBS Group’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$806K Buy
353,667
+37,440
+12% +$85.4K ﹤0.01% 4505
2025
Q1
$490K Buy
316,227
+115,995
+58% +$180K ﹤0.01% 4686
2024
Q4
$471K Buy
200,232
+43,254
+28% +$102K ﹤0.01% 4738
2024
Q3
$570K Buy
156,978
+21,187
+16% +$76.9K ﹤0.01% 4004
2024
Q2
$473K Buy
135,791
+42,943
+46% +$149K ﹤0.01% 3960
2024
Q1
$592K Buy
92,848
+8,193
+10% +$52.3K ﹤0.01% 3969
2023
Q4
$545K Buy
84,655
+2,345
+3% +$15.1K ﹤0.01% 3914
2023
Q3
$192K Buy
82,310
+12,217
+17% +$28.5K ﹤0.01% 4297
2023
Q2
$167K Buy
70,093
+5,726
+9% +$13.6K ﹤0.01% 4570
2023
Q1
$118K Buy
64,367
+47,368
+279% +$87.2K ﹤0.01% 4727
2022
Q4
$32.3K Sell
16,999
-24,776
-59% -$47.1K ﹤0.01% 5994
2022
Q3
$89K Sell
41,775
-298
-0.7% -$635 ﹤0.01% 4747
2022
Q2
$118K Sell
42,073
-31,785
-43% -$89.1K ﹤0.01% 4308
2022
Q1
$308K Buy
73,858
+64,808
+716% +$270K ﹤0.01% 4076
2021
Q4
$47K Buy
9,050
+1,555
+21% +$8.08K ﹤0.01% 5860
2021
Q3
$49K Sell
7,495
-8,586
-53% -$56.1K ﹤0.01% 5243
2021
Q2
$107K Sell
16,081
-2,633
-14% -$17.5K ﹤0.01% 4791
2021
Q1
$107K Buy
18,714
+13,170
+238% +$75.3K ﹤0.01% 4925
2020
Q4
$50K Buy
5,544
+2,285
+70% +$20.6K ﹤0.01% 5185
2020
Q3
$38K Sell
3,259
-1,639
-33% -$19.1K ﹤0.01% 4975
2020
Q2
$79K Buy
4,898
+1,665
+52% +$26.9K ﹤0.01% 4664
2020
Q1
$19K Hold
3,233
﹤0.01% 5614
2019
Q4
$43K Sell
3,233
-2
-0.1% -$27 ﹤0.01% 5379
2019
Q3
$40K Sell
3,235
-3
-0.1% -$37 ﹤0.01% 5366
2019
Q2
$52K Buy
+3,238
New +$52K ﹤0.01% 5029
2019
Q1
Sell
-884
Closed -$29K 6852
2018
Q4
$29K Buy
884
+808
+1,063% +$26.5K ﹤0.01% 5588
2018
Q3
$2K Sell
76
-216
-74% -$5.68K ﹤0.01% 6795
2018
Q2
$8K Buy
+292
New +$8K ﹤0.01% 6325